Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Women's Choice Pharmaceuticals has introduced Skinvisible Pharmaceuticals' prescription product ProCort in the US.
Subscribe to our email newsletter
Procort, formulated by Skinvisible’s patented polymer delivery system Invisicare, is a kind of topical steroid that helps in reducing swelling, redness, allergic reactions and itching.
Earlier, Skinvisible has licensed Women’s Choice Pharma to commercialize its product in the US.
As per the deal, Skinvisible has received a development fee and now eligible to receive a license fee from Women’s Choice Pharma paid in milestones plus on-going royalties based on product sales.